Loading company…
May Health is a Paris-based clinical-stage medical device company developing treatments for polycystic ovary syndrome.
Founded in 2017 and based in Paris, France, May Health US Inc. offers ovarian rebalancing, a treatment that aims to restore ovulation through targeted ovarian ablation, for women with polycystic ovary syndrome. In March 2026 the company raised EUR 10 million in growth capital from Sofinnova Partners, Trill Impact, Bpifrance Investissement, and Nexpring Health. The funds will support the pivotal United States Investigational Device Exemption trial and European launch planning for the Anavi System. Its stage is Series B, and Anne Morrissey is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in